From - A Hematology Oncology Wiki
Jump to navigation Jump to search
Samuel Rubinstein, MD

Samuel Rubinstein MD is a Clinical Assistant Professor of Medicine in the Division of Hematology at the University of North Carolina-Chapel Hill Lineberger Comprehensive Cancer Center. His current research focuses on exploring outcomes and conducting clinical trials for patients with plasma cell dyscrasias including multiple myeloma and AL amyloidosis. He is also the site PI at UNC for the COVID-19 and Cancer Consortium (CCC-19). He is the Section Editor of Plasma Cell Dyscrasias.